Genomics research startup MedGenome raised $50 millionin funds led by Novo Holdings

Share via:

Genomics research startup MedGenome raised $50 million as part of a strategic funding round led by life sciences investor Novo Holdings where existing investors such as LeapFrog Investments and Sofina also participated.

MedGenome is a genomics research and diagnostics firm that provides a wide range of products, including genetic testing and drug discovery solutions. The funding will be used to expand the startup’s geographical footprint beyond South Asia into Africa and the Middle East. MedGenome will also use the funds to expand its product line and expand the reach of its diagnostic services in the reproductive and oncology domains. It will also increase its investments in bioinformatics and software-as-a-service (SaaS).

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Popular

More Like this

Genomics research startup MedGenome raised $50 millionin funds led by Novo Holdings

Genomics research startup MedGenome raised $50 million as part of a strategic funding round led by life sciences investor Novo Holdings where existing investors such as LeapFrog Investments and Sofina also participated.

MedGenome is a genomics research and diagnostics firm that provides a wide range of products, including genetic testing and drug discovery solutions. The funding will be used to expand the startup’s geographical footprint beyond South Asia into Africa and the Middle East. MedGenome will also use the funds to expand its product line and expand the reach of its diagnostic services in the reproductive and oncology domains. It will also increase its investments in bioinformatics and software-as-a-service (SaaS).

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Website Upgradation is going on for any glitch kindly connect at office@startupnews.fyi

More like this

Data Management Maestro, The Expertise and Leadership of Siva...

New Delhi (India) April 3: Siva Karthik Devineni, a...

Meta pauses plans to train AI using European users’...

Meta has confirmed that it will pause plans...

KreditBee Subsidiary KB NBFC Raises $32 Mn In Debt...

SUMMARY KB NBFC raised the debt funding from Yubi,...

Popular

Upcoming Events

Startup Information that matters. Get in your inbox Daily!